CVS · CVS Health Corp.
$104.342026-07-21Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Bull
$842
+707.4% vs market
Base · active
$633
+506.8% vs market
Bear
$625
+498.6% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($625 · $842) Analysts Range ($90 · $115) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q1 | $357.8B | — | 3.8% | 25.6% | $10.2B | −$9.1B | $1.1B | 6.9% | — | 8.1% | $126.9B | $6.52 | — |
| 2024.Q4 | $357.8B | 0.0% | 3.8% | 25.4% | $10.3B | $1.8B | $12.1B | 6.6% | — | 7.9% | $132.6B | $6.52 | — |
| 2025.Q1 | $372.8B | 4.2% | 2.3% | 27.0% | $6.2B | $519MM | $6.7B | 7.3% | — | 4.7% | $130.9B | $3.61 | — |
| 2025.Q4 | $372.8B | 0.0% | 2.3% | 19.1% | $6.9B | −$3.2B | $3.7B | 7.3% | — | 5.0% | $143.2B | $3.61 | — |
| 2026.Q1 | $407.9B | 9.4% | 1.5% | 16.4% | $5.0B | −$4.7B | $265MM | 7.6% | — | 3.6% | $130.7B | $2.29 | 22.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.2% |
| 2027.Q1 | $412.9B | +1.2% | 2.6% | 16.8% | $8.9B | −$2.8B | $6.1B | 7.7% | $5.7B | 6.8% | $133.4B | $6.97 | 15.0 |
| 2028.Q1 | $431.8B | +4.6% | 2.8% | 17.1% | $10.0B | −$8.5B | $1.5B | 7.8% | $1.3B | 7.3% | $141.9B | $7.82 | 13.3 |
| 2029.Q1 | $456.5B | +5.7% | 3.0% | 17.5% | $11.4B | −$9.2B | $2.1B | 7.9% | $1.7B | 7.8% | $151.2B | $8.90 | 11.7 |
| 2030.Q1 | $483.3B | +5.9% | 3.2% | 17.9% | $12.8B | −$14.9B | −$2.1B | 8.0% | −$1.5B | 8.1% | $166.1B | $10.05 | 10.4 |
| 2031.Q1 | $504.1B | +4.3% | 3.2% | 18.2% | $13.3B | −$11.1B | $2.2B | 8.1% | $1.5B | 7.8% | $177.2B | $10.43 | 10.0 |
|
| Term. Yr+ | $643.8B | 4.1% | 17.5% | 20.0% | $90.1B | −$15.7B | $74.5B | 8.6% | $758.0B | 23.6% | — | — | — |
Active scenario IV: $633 (+506.8% vs market)